For the past 15 years, Seattle Children’s Research Division has been at the forefront of breakthrough innovations. From new drugs to treat cystic fibrosis, to first-in-the-nation use of laser ablation for epilepsy and brain tumors to remove unwanted cells, the research division is advancing our mission to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible.
Here, we take a look at some of the achievements of the past decade-and-a-half.
Dr. Bonnie Ramsey’s research led to several major breakthroughs in cystic fibrosis, including the eventual FDA approval of three new pediatric medications for the disease. These medical advances dramatically increase the life expectancy of children with cystic fibrosis.
Seattle Children’s Therapeutics has designed, manufactured and launched a robust portfolio of immunotherapy clinical trials for childhood cancer since 2012. The world-class Therapeutic Cell Manufacturing facility will soon have the potential to make cell products for up to 1,000 children a year, compared to 120 per year currently. Seattle Children’s has the most comprehensive CAR T-cell immunotherapy program for pediatric patients in the world, so we can treat more types of childhood cancers such as leukemia and lymphoma, solid tumors and brain tumors using those therapies than any other facility.
